Maintenance Vitamin C Infusion

Once a patient has completed a full treatment course of IV vitamin C at IVC Olomouc, the maintenance infusion provides a cost-effective way to preserve elevated plasma vitamin C levels over time. At 600 Kč per session — slightly less than the standard 650 Kč single dose — this protocol is tailored for patients in recovery, those managing chronic conditions, or anyone who wants to keep immune defences primed between seasonal or therapeutic courses. The practitioner guides the recommended frequency based on the patient's baseline health and response to prior sessions.

Intravenous vitamin C exerts its effects transiently — plasma concentrations peak within an hour of the infusion and return to baseline within several hours as the kidneys excrete the excess ascorbic acid. This rapid clearance means that long-term benefits depend on repeated exposure rather than a single high dose. The maintenance infusion at IVC Olomouc is designed to bridge the gap between intensive courses, keeping tissue vitamin C stores replenished in patients who have already demonstrated good tolerance and benefit from the treatment. At 600 Kč, it is priced slightly below the standard single-dose rate of 650 Kč, reflecting its role as a follow-up rather than an introductory session. The protocol uses the same 7.5g ascorbic acid concentration as the standard single dose, delivered over approximately 45–60 minutes via peripheral IV. It is appropriate for patients in post-surgical recovery, those managing chronic fatigue syndrome or recurring infections, oncology patients between active treatment cycles, and individuals who found seasonal courses beneficial and want to sustain that immunity year-round. The practitioner at IVC Olomouc assesses optimal frequency during the initial course — common maintenance schedules are monthly or seasonal, depending on exposure risk and the patient's underlying health. No special preparation is required beyond those for a standard infusion: eat beforehand, stay hydrated, and inform the practitioner of any changes in medication or health status since the last session. Patients who have already been through the screening process for G6PD deficiency do not need to repeat it unless their clinical picture has changed.